The company
Veracyte, Inc.
VCYT · Nasdaq
Health CareDiagnostics & LabsJust dropped out
VCYT stood above a rising 150-day average in 36 of the last 52 weekly readings, and has been out of that trend for the last 1 week. It is 2.1% below that average now. Diagnostics & Labs: 48% of its 44 stocks in an uptrend (−2 points in four weeks); Health Care: 25% (−11 points in four weeks).
Statistics
- Rotation
- Just dropped out
- Weeks in an uptrend
- out for 1
- Industry in uptrend
- 48% -2 in 4 wk
- Insider buys, 12 months
- $0
- Insider sales, 12 months
- $35.6M
- Officials’ trades on record
- 16
- Institutions holding
- 341 (+31)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 36 of 52 weeks.
17 Apr – 16 Oct
Diagnostics & Labs: About half its stocks are in an uptrend and the share has held steady. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
1 Nov 2024 – 1 Oct 2026
Open-market buys above the line and sales below, in dollars.
Congress and officials
16 disclosed lines: House 15, Senate 0, executive 1; 5 people.
| Who | Did | Amount | Traded |
|---|---|---|---|
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | sold | $15k–$50k | 29 Jul 2026filed 22 Sep 2026 |
| Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA31 | bought | $1k–$15k | 3 Mar 2026filed 7 Apr 2026 |
| Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA31 | bought | $1k–$15k | 18 Feb 2026filed 9 Mar 2026 |
| Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA31 | sold | $1k–$15k | 12 Nov 2025filed 15 Dec 2025 |
| Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA31 | bought | $1k–$15k | 16 Jun 2025filed 10 Jul 2025 |
| Josh Gottheimer House: U.S. House ClerkNJ05 | boughtjoint | $1k–$15k | 16 Oct 2023filed 11 Nov 2023 |
| Josh Gottheimer House: U.S. House ClerkNJ05 | soldjoint | $1k–$15k | 15 Sep 2023filed 15 Oct 2023 |
| Daniel S. Goldman House: U.S. House ClerkNY10 | sold | $1k–$15k | 10 Apr 2023filed 19 May 2023 |
| Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA39 | sold | $1k–$15k | 23 Dec 2020filed 11 Jan 2021 |
| Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA39 | sold | $1k–$15k | 10 Dec 2020filed 11 Jan 2021 |
| Josh Gottheimer House: U.S. House ClerkNJ05 | sold | $1k–$15k | 8 Dec 2020filed 7 Jan 2021 |
| Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA39 | sold | $1k–$15k | 29 Oct 2020filed 5 Nov 2020 |
Insiders
Buy orders, 12 months0
Sale orders, 12 months34
Buyers · sellers0 · 11
| Who | Did | Shares | Traded |
|---|---|---|---|
| John LeiteGlobal Chief Commercial Off | sold | 4,015at $40.00 | 21 Sep 2026filed 22 Sep 2026 |
| Jens HolsteinDirector | sold | 5,000at $40.95 | 14 Sep 2026filed 16 Sep 2026 |
| Phillip G. FebboChief Scientific & Med Officer | sold | 10,405at $42.89 | 4 Sep 2026filed 4 Sep 2026 |
| Phillip G. FebboChief Scientific & Med Officer | sold | 2,705at $43.66 | 4 Sep 2026filed 4 Sep 2026 |
| Rebecca ChambersChief Financial Officer | sold | 2,477at $42.81 | 4 Sep 2026filed 4 Sep 2026 |
| Rebecca ChambersChief Financial Officer | sold | 1,175at $43.71 | 4 Sep 2026filed 4 Sep 2026 |
| Annie McGuireEVP, General Counsel | sold | 2,154at $42.79 | 4 Sep 2026filed 4 Sep 2026 |
| Annie McGuireEVP, General Counsel | sold | 1,100at $43.67 | 4 Sep 2026filed 4 Sep 2026 |
| Muna BhanjiDirector | sold | 1,864at $42.97 | 1 Sep 2026filed 3 Sep 2026 |
| Karin EasthamDirector | sold | 3,200at $52.78 | 18 Jun 2026filed 22 Jun 2026 |
| Karin EasthamDirector | sold | 529at $53.55 | 18 Jun 2026filed 22 Jun 2026 |
| Marc StapleyChief Executive Officer | sold | 138,051at $50.12 | 4 Jun 2026filed 4 Jun 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Holders341+31 on the quarter
New · exited76 · 43
Reported value$5.2B
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| BlackRock, Inc.added · filed 7 Aug 2026 | 13,486,437$792.1M | +313,819+2.4% |
| FMR LLCreduced · filed 13 Aug 2026 | 7,702,746$452.4M | -61,103−0.8% |
| Artisan Partners Limited Partnershipadded · filed 13 Aug 2026 | 5,538,404$325.3M | +42,034+0.8% |
| VANGUARD PORTFOLIO MANAGEMENT LLCadded · filed 13 Aug 2026 | 4,716,191$277.0M | +271,461+6.1% |
| STATE STREET CORPreduced · filed 7 Aug 2026 | 4,698,128$276.0M | -345,462−6.8% |
| VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026 | 3,593,922$211.1M | +61,690+1.7% |
| DIMENSIONAL FUND ADVISORS LPreduced · filed 11 Aug 2026 | 2,826,524$166.0M | -54,566−1.9% |
| FIRST TRUST ADVISORS LPadded · filed 11 Aug 2026 | 2,507,902$147.3M | +390,856+18.5% |
| ARK Investment Management LLCreduced · filed 14 Aug 2026 | 2,295,951$134.8M | -757,867−24.8% |
| WELLINGTON MANAGEMENT GROUP LLPreduced · filed 14 Aug 2026 | 2,274,160$133.6M | -284,125−11.1% |
31 Mar 2023 – 30 Jun 2026
Everyone who traded it
Same industry
Government contracts
Awards9
Total$1.6M
Latest1 Oct 2026
FY27 TASK ORDER FOR VERACYTE THYROID TESTING SERVICESDepartment of Veterans Affairs · $68K · 1 Oct 2026OPTION YEAR 2 FOR TESTING --EO 14398Department of Veterans Affairs · $13K · 1 Oct 2026TO - PROSTATE TESTINGDepartment of Veterans Affairs · $345K · 1 Feb 2026DECIPHER PROSTATE TESTING ANN ARBOR, SAGINAW, BATTLE CREEK - BASEDepartment of Veterans Affairs · $259K · 15 Nov 2025
From its SEC filings
Analyst forecasts
No analyst forecasts yet.